Burden of gastrointestinal disease in U.S. substantial

October 29, 2012
Burden of gastrointestinal disease in U.S. substantial
Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology.

(HealthDay)—Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology.

Anne F. Peery, M.D., from the University of North Carolina in Chapel Hill, and colleagues reviewed data on the epidemiology of collected from the National Ambulatory Medical Care Survey; National Health and Wellness Survey; Nationwide Inpatient Sample; Surveillance, Epidemiology, and End Results Program; National Vital Statistics System; Thompson Reuters MarketScan; Medicare; Medicaid; and the Clinical Outcomes Research Initiative's National Endoscopic Database. Endoscopic use, costs, and trends were examined.

The researchers found that the most common gastrointestinal symptom prompting a clinic visit was abdominal pain (15.9 million visits) and the most common gastrointestinal diagnosis was gastroesophageal reflux (8.9 million visits). In the last 10 years, hospitalizations and mortality from Clostridium difficile infection doubled. The most common reason for hospitalization (274,119 discharges) was acute pancreatitis. Colorectal cancer was the leading cause of gastrointestinal-related mortality (52,394 deaths) and accounted for more than half of all . In 2009 there were 6.9 million upper, 11.5 million lower, and 228,000 biliary endoscopies performed, with total costs of $32.4 billion for outpatient gastrointestinal endoscopy examinations.

"In summary, we present a comprehensive and current estimate of the toll of gastrointestinal and in the United States," the authors write. "Payers, policy makers, clinicians, and others interested in resource utilization may use these statistics to better understand evolving disease trends and the best way to meet the challenge of these diseases."

Explore further: Death from GI bleeding decreased in United States in past two decades

More information: Abstract
Full Text

Related Stories

Recommended for you

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

How gut bacteria change cancer drug activity

April 21, 2017

The activity of cancer drugs changes depending on the types of microbes living in the gut, according to a UCL-led study into how nematode worms and their microbes process drugs and nutrients.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.